A new drug jointly developed and submitted for marketing approval globally in China, the US, Japan and other countries, has been approved for market launch in China first, and can be used for patients of “sudden sleep attacks,” China Central Television(CCTV) News reported Tuesday, citing National Medical Products Administration.